Manipulation of β-catenin pathway to overcome endocrine resistance in breast cancer.

被引：0
|
作者：
Won, Hye Sung
Lee, Kyoung Eun
Lee, Kyung Mee
Nam, Eun Mi
Mun, Yeung Chul
Seong, Chu-Myong
Lee, Soon-Nam
机构：
[1] Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Internal Med, Gyeonggi Do, South Korea
[2] Ewha Womans Univ Hosp, Seoul, South Korea
[3] Ewha Womans Univ, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea
[4] Ewha Womans Univ, Seoul, South Korea
[5] Ewha Womans Univ, Sch Med, Seoul, South Korea
[6] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea
[7] Ewha Womans Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e11530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11530
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Mechanisms of Endocrine Resistance in Breast Cancer
    Osborne, C. Kent
    Schiff, Rachel
    ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 : 233 - 247
  • [32] Resistance to endocrine therapy in breast cancer
    Kurebayashi, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (Suppl 1) : S39 - S46
  • [33] Acquired endocrine resistance in breast cancer
    Nature Reviews Endocrinology, 2014, 10 (2) : 66 - 66
  • [34] Overcoming Endocrine Resistance in Breast Cancer
    Hanker, Ariella B.
    Sudhan, Dhivya R.
    Arteaga, Carlos L.
    CANCER CELL, 2020, 37 (04) : 496 - 513
  • [35] Autophagy and endocrine resistance in breast cancer
    Cook, Katherine L.
    Shajahan, Ayesha N.
    Clarke, Robert
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1283 - 1294
  • [36] Resistance to endocrine therapy in breast cancer
    Junichi Kurebayashi
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 39 - 46
  • [37] Mechanisms of endocrine resistance in breast cancer
    Per E Lnning
    中华乳腺病杂志(电子版), 2012, 6 (06) : 597 - 608
  • [38] Statins and endocrine resistance in breast cancer
    Hyder, Tara
    Marti, Juan Luis Gomez
    Nasrazadani, Azadeh
    Brufsky, Adam M.
    CANCER DRUG RESISTANCE, 2021, 4 (02) : 356 - 364
  • [39] Targeting MET and RON to overcome cetuximab resistance in colorectal cancer.
    Graves-Deal, Ramona
    Bogatcheva, Galina
    Damalanka, Vishnu
    Klampfer, Lidija
    Janetka, James W.
    Coffey, Robert J.
    Singh, Bhuminder
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Mechanisms and strategies to overcome resistance to enfortumab vedotin in bladder cancer.
    Chang, Kevin
    Lodha, Roshan
    Delavan, Henry M.
    Winebaum, Jenna
    Porten, Sima P.
    Feng, Felix Y.
    Chu, Carissa E.
    Chou, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 690 - 690
12345